MAb114 (VRC-EBOMAB092-00-AB)

MAb114 · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAb114 (VRC-EBOMAB092-00-AB), covering 2018-10-11 to 2018-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults [Phase 1]

See pricing